Khiron announces closing of $12.93 million prospectus financing including full exercise of over-allotment option TORONTO, Sept. 12, 2018 /CNW/ – Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV:KHRN, OTCQB:KHRNF), a Canadian integrated medical cannabis company with its core operations in Colombia, is pleased to announce that it has closed today its previously announced best … Continue reading Khiron Raises $12.9 Million to Expand Colombia Medical Cannabis Operations